Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
The Friends reception took place on Tuesday, August 10, 2010 from 3:30 – 4:30 p.m. in the 8th floor Ziemann Suite. This event brought together more than 80 people, including members of the Friend's organization and faculty, staff, and students of the Waisman Center. The program featured an update on the previous year's activities and achievements at the Waisman Center by center director Marsha Mailick Seltzer, PhD.
A team of scientists from the School of Medicine and Public Health has successfully grown multiple types of retina cells from two types of stem cells — suggesting a future in which damaged retinas could be repaired by cells grown from the patient's own skin.
WiCell Research Institute and Waisman Clinical Biomanufacturing Facility offer new stem cell banks to support translational research through clinical applications The WiCell™ Research Institute and the Waisman Clinical Biomanufacturing Facility (WCBF) announced today the release of the first current Good Manufacturing Practices (cGMP) feeder-independent pluripotent stem cell banks available for sale and distribution to …
Stressful experiences in early childhood can have long-lasting impacts on kids' health that persist well beyond the resolution of the situation.
A network of emotion-regulating brain regions implicated in the pathological worry that can grip patients with anxiety disorders may also be useful for predicting the benefits of treatment.
When neurons started dying in Clive Svendsen's lab dishes, he couldn't have been more pleased.
There are many ways to die, but amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease must be one of the worst.
Research at UW-Madison has already shown that meditation can change the brain. Now a new grant will allow a more in-depth investigation of how these changes can affect sleep, pain tolerance, emotion regulation and other measures of well-being.
"Don’t give up, my love, or I’ll give up with you, because I only live to see the fulfillment of this dream: that you may continue to live. Yours is a life sentence, not a death sentence.”
"The novelty is that this is a combined cell and gene therapy approach," Suzuki explains, noting that the bone marrow stem cells on their own had a modest effect, possibly by releasing their own protective factors. "But only when we engineered the cells to release GDNF did we see a significant improvement. The cells turned out to be quite an important component. It's this combination of cells and drug delivery that seems to be so effective."
